Trials / Conditions / Amyloid Neuropathies, Familial
Amyloid Neuropathies, Familial
6 registered clinical trials studyying Amyloid Neuropathies, Familial — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 3 Study of NTLA-2001 in ATTRv-PN NCT06672237 | Intellia Therapeutics | Phase 3 |
| Completed | Early and Systematic Screening in Chronic Neuropathy NCT03720275 | University Hospital, Bordeaux | N/A |
| Completed | Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis NCT03431896 | The Cleveland Clinic | — |
| Completed | ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Fa NCT02319005 | Alnylam Pharmaceuticals | Phase 3 |
| Completed | APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)- NCT01960348 | Alnylam Pharmaceuticals | Phase 3 |
| Approved For Marketing | Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) NCT02939820 | Alnylam Pharmaceuticals | — |